Pacific Center for Financial Services’s iShares Genomics Immunology and Healthcare ETF IDNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$16.1K Buy
553
+3
+0.5% +$87 ﹤0.01% 293
2025
Q4
$13K Hold
550
﹤0.01% 303
2025
Q3
$13K Hold
550
﹤0.01% 303
2025
Q2
$11.3K Sell
550
-183
-25% -$3.69K ﹤0.01% 298
2025
Q1
$15K Sell
733
-124
-14% -$2.77K ﹤0.01% 275
2024
Q4
$19.4K Buy
857
+4
+0.5% +$96 0.01% 257
2024
Q3
$21K Hold
853
0.01% 248
2024
Q2
$19.7K Buy
853
+4
+0.5% +$94 0.01% 243
2024
Q1
$20.4K Hold
849
0.01% 245
2023
Q4
$19.5K Buy
849
+6
+0.7% +$121 0.01% 230
2023
Q3
$17.1K Hold
843
0.01% 251
2023
Q2
$19.7K Buy
843
+3
+0.4% +$72 0.01% 234
2023
Q1
$19.6K Buy
+840
New +$21K 0.01% 232
2022
Q3
$22K Hold
840
0.01% 216
2022
Q2
$24K Buy
840
+4
+0.5% +$119 0.01% 203
2022
Q1
$29K Sell
836
-201
-19% -$7.1K 0.01% 193
2021
Q4
$45K Buy
1,037
+325
+46% +$15.4K 0.02% 171
2021
Q3
$36K Buy
+712
New +$37.1K 0.02% 184

Other funds holding IDNA